Psoriasis: all 1,928 studies

Page 7 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.

• Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis SubjectsTerminatedNCT01708590Phase 3Results posted
• Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel FormulationCompletedNCT01707368Results posted
• Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis VulgarisCompletedNCT01707043Phase 4Results posted
• Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque PsoriasisTerminatedNCT01704599Phase 1/2Results posted
• A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque PsoriasisCompletedNCT01700985Phase 2Results posted
• Pharmacokinetics of 122-0551 and Its Effects on Adrenal SuppressionCompletedNCT01698333Phase 2Results posted
• A Study of Ixekizumab in Participants With Active Psoriatic ArthritisCompletedNCT01695239Phase 3Results posted
• Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque PsoriasisCompletedNCT01690299Phase 3Results posted
• A Clinical Study of Increased Dose of TA-650 in Patients With PsoriasisCompletedNCT01680159Phase 3Results posted
• A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)CompletedNCT01646177Phase 3Results posted
• Safety and Efficacy Study of Adalimumab in the Treatment of Plaque PsoriasisCompletedNCT01646073Phase 3Results posted
• An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian FederationCompletedNCT01644396Phase 4Results posted
• 4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type PsoriasisCompletedNCT01640951Phase 3Results posted
• Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)CompletedNCT01636687Phase 3Results posted
• A Study in Japanese Participants With Moderate-to-Severe PsoriasisCompletedNCT01624233Phase 3Results posted
• Prospective Evaluation of the Radiographic Efficacy of EnbrelCompletedNCT01623752Results posted
• Trial of IMO-3100 in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT01622348Phase 2Results posted
• A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque PsoriasisCompletedNCT01610596Phase 2Results posted
• A Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis VulgarisCompletedNCT01607853Phase 2Results posted
• Effect of LEO 90100 on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisExtensive Psoriasis VulgarisCompletedNCT01600222Phase 2Results posted
• A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)CompletedNCT01597245Phase 3Results posted
• A Plaque Test Study With LEO 35299 in Psoriasis VulgarisCompletedNCT01580488Phase 1Results posted
• An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement CriteriaCompletedNCT01557283Results posted
• First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 WeeksCompletedNCT01555125Phase 3Results posted
• Vascular Inflammation in Psoriasis Trial (The VIP Trial)CompletedNCT01553058Phase 4Results posted
• A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque PsoriasisCompletedNCT01550744Phase 3Results posted
• Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With SecukinumabCompletedNCT01544595Phase 3Results posted
• Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to AdalimumabTerminatedNCT01543204Phase 4Results posted
• Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis PatientsCompletedNCT01537432Phase 2Results posted
• LEO 90100 in the Treatment of Psoriasis VulgarisCompletedNCT01536938Phase 2Results posted
• LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis VulgarisCompletedNCT01536886Phase 2Results posted
• A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic ArthritisCompletedNCT01519089Phase 3Results posted
• The Quality of Life Study in Psoriasis Patients After Ustekinumab TreatmentCompletedNCT01511315Phase 4Results posted
• A Phase 2b Study of Baricitinib in Participants With Moderate to Severe PsoriasisCompletedNCT01490632Phase 2Results posted
• Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT01483924Phase 2Results posted
• A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type PsoriasisCompletedNCT01483599Phase 2Results posted
• A Phase 3 Study in Participants With Moderate to Severe PsoriasisCompletedNCT01474512Phase 3Results posted
• Comparison of Indigo Naturalis Oil Extract and Calcipotriol Solution in Treating PsoriasisCompletedNCT01445886Phase 2/3Results posted
• Nurse Education in Subjects With Psoriasis Undergoing Treatment With AdalimumabCompletedNCT01435265Not applicableResults posted
• LEO 90105 Ointment in Japanese Subjects With PsoriasisCompletedNCT01422434Phase 3Results posted
• Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type PsoriasisCompletedNCT01412944Phase 3Results posted
• Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose RegimensCompletedNCT01406938Phase 3Results posted
• Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbiditiesCompletedNCT01401452Results posted
• Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in PsoriasisCompletedNCT01387815Results posted
• Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 YearCompletedNCT01365455Phase 3Results posted
• Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type PsoriasisCompletedNCT01358578Phase 3Results posted
• Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee PainCompletedNCT01351805Not applicableResults posted
• A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis VulgarisCompletedNCT01347255Phase 2Results posted
• Quality of Life and Psychosocial Factors Associated With Severe Psoriasis Following Treatment With AdalimumabCompletedNCT01328366Results posted
• Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.CompletedNCT01320293Not applicableResults posted
• Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab TreatmentCompletedNCT01316224Results posted
• Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque PsoriasisCompletedNCT01313221Phase 3Results posted
• A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque PsoriasisCompletedNCT01309737Phase 3Results posted
• AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type PsoriasisCompletedNCT01300052Phase 2Results posted
• A Study to Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)CompletedNCT01276847Phase 1Results posted
• A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque PsoriasisCompletedNCT01276639Phase 3Results posted
• A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis VulgarisCompletedNCT01268527Phase 2Results posted
• Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT01265823Phase 4Results posted
• Trial of CF101 to Treat Patients With PsoriasisCompletedNCT01265667Phase 2/3Results posted
• A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. MethotrexateCompletedNCT01251614Phase 3Results posted
• CP-690-550 Ointment For Chronic Plaque PsoriasisCompletedNCT01246583Phase 2Results posted
• Efficacy of Alitretinoin Treatment in Patients With Pustular Form of PsoriasisCompletedNCT01245140Phase 2Results posted
• A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque PsoriasisCompletedNCT01241591Phase 3Results posted
• A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)CompletedNCT01235728Phase 1Results posted
• Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT01235442Phase 3Results posted
• Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.CompletedNCT01232283Phase 3Results posted
• A Study to Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003)CompletedNCT01225731Phase 2Results posted
• Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT01206660Phase 3Results posted
• Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque PsoriasisCompletedNCT01206387Phase 3Results posted
• Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical PracticeCompletedNCT01202565Results posted
• Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp PsoriasisCompletedNCT01195831Phase 3Results posted
• Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT01194219Phase 3Results posted
• LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)CompletedNCT01188928Phase 3Results posted
• A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque PsoriasisCompletedNCT01186744Phase 3Results posted
• A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type PsoriasisCompletedNCT01177800Phase 3Results posted
• Psoriasis Inflammation and Systemic Co MorbiditiesCompletedNCT01170715Not applicableResults posted
• Evaluation of Humira Retention Rate in Psoriasis Patients in Daily Practice and Assessment of Work Productivity and Quality of LifeCompletedNCT01169987Results posted
• Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque PsoriasisCompletedNCT01166646Phase 2Results posted
• A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque PsoriasisTerminatedNCT01163253Phase 3Results posted
• Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab TherapyTerminatedNCT01156532Results posted
• Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation)CompletedNCT01155570Results posted
• Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type PsoriasisCompletedNCT01154101Phase 2Results posted
• Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology PracticeCompletedNCT01147874Phase 4Results posted
• Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020)CompletedNCT01140061Phase 1Results posted
• The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body PsoriasisCompletedNCT01139580Phase 3Results posted
• Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult PopulationCompletedNCT01137032Phase 4Results posted
• AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe PsoriasisCompletedNCT01132612Phase 2Results posted
• A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors in Patients With Moderate to Severe PsoriasisCompletedNCT01126619Results posted
• Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp PsoriasisCompletedNCT01120223Phase 2Results posted
• A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis VulgarisCompletedNCT01116895Phase 2Results posted
• Ammonium Lactate Lotion 12% (Lac-hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of PsoriasisCompletedNCT01111123Phase 4Results posted
• A Study in Participants With Moderate to Severe PsoriasisCompletedNCT01107457Phase 2Results posted
• Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With PsoriasisTerminatedNCT01101100Phase 2Results posted
• Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric PsoriasisCompletedNCT01100034Results posted
• Acitretin or Tazarotene Gel and Excimer Laser for Treatment of PsoriasisTerminatedNCT01094717Not applicableResults posted
• A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)CompletedNCT01090427Phase 3Results posted
• Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar PsoriasisCompletedNCT01090063Not applicableResults posted
• Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic DrugsCompletedNCT01084668Results posted
• Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp PsoriasisCompletedNCT01083758Phase 2Results posted
• Surveillance of Humira Injection in Korean PatientsCompletedNCT01083121Results posted

← Psoriasis overview